|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen S, Li YF, Feng XY, Zhou ZW, Yuan XH
and Chen YB: Significance of palliative gastrectomy for late-stage
gastric cancer patients. J Surg Oncol. 106:862–871. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bando E, Yonemura Y, Takeshita Y,
Taniguchi K, Yasui T, Yoshimitsu Y, Fushida S, Fujimura T,
Nishimura G and Miwa K: Intraoperative lavage for cytological
examination in 1,297 patients with gastric carcinoma. Am J Surg.
178:256–262. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sachlova M, Majek O and Tucek S:
Prognostic value of scores based on malnutrition or systemic
inflammatory response in patients with metastatic or recurrent
gastric cancer. Nutr Cancer. 66:1362–1370. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ando M, Ando Y, Hasegawa Y, Shimokata K,
Minami H, Wakai K, Ohno Y and Sakai S: Prognostic value of
performance status assessed by patients themselves, nurses, and
oncologists in advanced non-small cell lung cancer. Br J Cancer.
85:1634–1639. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nozoe T, Korenaga D, Futatsugi M, Saeki H,
Maehara Y and Sugimachi K: Immunohistochemical expression of
C-reactive protein in squamous cell carcinoma of the
esophagus-significance as a tumor marker. Cancer Lett. 192:89–95.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hashimoto K, Ikeda Y, Korenaga D, Tanoue
K, Hamatake M, Kawasaki K, Yamaoka T, Iwatani Y, Akazawa K and
Takenaka K: The impact of preoperative serum C-reactive protein on
the prognosis of patients with hepatocellular carcinoma. Cancer.
103:1856–1864. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Forrest LM, McMillan DC, McArdle CS,
Angerson WJ and Dunlop DJ: Evaluation of cumulative prognostic
scores based on the systemic inflammatory response in patients with
inoperable non-small-cell lung cancer. Br J Cancer. 89:1028–1030.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Crumley AB, McMillan DC, McKernan M,
McDonald AC and Stuart RC: Evaluation of an inflammation-based
prognostic score in patients with inoperable gastro-oesophageal
cancer. Br J Cancer. 94:637–641. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ishizuka M, Nagata H, Takagi K, Horie T
and Kubota K: Inflammation-based prognostic score is a novel
predictor of postoperative outcome in patients with colorectal
cancer. Ann Surg. 246:1047–1051. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Crumley AB, Stuart RC, McKernan M,
McDonald AC and McMillan DC: Comparison of an inflammation-based
prognostic score (GPS) with performance status (ECOG-ps) in
patients receiving palliative chemotherapy for gastroesophageal
cancer. J Gastroenterol Hepatol. 23:e325–e329. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Roxburgh CS, Crozier JE, Maxwell F, Foulis
AK, Brown J, McKee RF, Anderson JH, Horgan PG and McMillan DC:
Comparison of tumour-based (Petersen Index) and inflammation-based
(Glasgow Prognostic Score) scoring systems in patients undergoing
curative resection for colon cancer. Br J Cancer. 100:701–706.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kinoshita A, Onoda H, Imai N, Iwaku A,
Oishi M, Fushiya N, Koike K, Nishino H and Tajiri H: Comparison of
the prognostic value of inflammation-based prognostic scores in
patients with hepatocellular carcinoma. Br J Cancer. 107:988–993.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Roxburgh CS and McMillan DC: Role of
systemic inflammatory response in predicting survival in patients
with primary operable cancer. Future Oncol. 6:149–163. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gao Y and Huang D: The value of the
systematic inflammation-based Glasgow Prognostic Score in patients
with gastric cancer: A literature review. J Cancer Res Ther.
10:799–804. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Japanese Research Society for Gastric
Cancer, . Japanese Classification of Gastric Carcinoma. 1st
English. Tokyo: Kanehara & Co, Ltd; 1995
|
|
18
|
Andreyev HJ, Norman AR, Oates J and
Cunningham D: Why do patients with weight loss have a worse outcome
when undergoing chemotherapy for gastrointestinal malignancies? Eur
J Cancer. 34:503–509. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mantovani A, Allavena P, Sica A and
Balkwill F: Cancer-related inflammation. Nature. 454:436–444. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hwang JE, Kim HN, Kim DE, Choi HJ, Jung
SH, Shim HJ, Bae WK, Hwang EC, Cho SH and Chung IJ: Prognostic
significance of a systemic inflammatory response in patients
receiving first-line palliative chemotherapy for recurred or
metastatic gastric cancer. BMC Cancer. 11:4892011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Du Clos TW: Function of C-reactive
protein. Ann Med. 32:274–278. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Du Clos TW and Mold C: C-reactive protein:
An activator of innate immunity and a modulator of adaptive
immunity. Immunol Res. 30:261–277. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Slaviero KA, Clarke SJ and Rivory LP:
Inflammatory response: An unrecognised source of variability in the
pharmacokinetics and pharmacodynamics of cancer chemotherapy.
Lancet Oncol. 4:224–232. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
McMillan DC, Elahi MM, Sattar N, Angerson
WJ, Johnstone J and McArdle CS: Measurement of the systemic
inflammatory response predicts cancer-specific and non-cancer
survival in patients with cancer. Nutr Cancer. 41:64–69. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Imaoka H, Mizuno N, Hara K, Hijioka S,
Tajika M, Tanaka T, Ishihara M, Yogi T, Tsutsumi H, Fujiyoshi T, et
al: Evaluation of modified glasgow prognostic score for pancreatic
cancer: A retrospective cohort study. Pancreas. 45:211–217. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lien YC, Hsieh CC, Wu YC, Hsu HS, Hsu WH,
Wang LS, Huang MH and Huang BS: Preoperative serum albumin level is
a prognostic indicator for adenocarcinoma of the gastric cardia. J
Gastrointest Surg. 8:1041–1048. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lee J, Lim T, Uhm JE, Park KW, Park SH,
Lee SC, Park JO, Park YS, Lim HY, Sohn TS, et al: Prognostic model
to predict survival following first-line chemotherapy in patients
with metastatic gastric adenocarcinoma. Ann Oncol. 18:886–891.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Baron JA, Cole BF, Sandler RS, Haile RW,
Ahnen D, Bresalier R, McKeown-Eyssen G, Summers RW, Rothstein R,
Burke CA, et al: A randomized trial of aspirin to prevent
colorectal adenomas. N Engl J Med. 348:891–899. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Rothwell PM, Fowkes FG, Belch JF, Ogawa H,
Warlow CP and Meade TW: Effect of daily aspirin on long-term risk
of death due to cancer: Analysis of individual patient data from
randomised trials. Lancet. 377:31–41. 2011. View Article : Google Scholar : PubMed/NCBI
|
